26-A-13412-ACC THREE-YEAR REAL-WORLD OUTCOMES OF TRANSCATHETER PFO CLOSURE IN JAPAN: STROKE, ATRIAL FIBRILLATION, AND ANTITHROMBOTIC MANAGEMENT